MYO9B gene polymorphisms are associated with the risk of inflammatory bowel diseases

Ming-Jie Wang; Xiao-Liang Xu; Guo-Liang Yao; Qiang Yu; Chun-Fu Zhu; Zhi-Jun Kong; Hui Zhao; Li-Ming Tang; Xi-Hu Qin

doi:10.18632/oncotarget.11186

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers: Immunology:

MYO9B gene polymorphisms are associated with the risk of inflammatory bowel diseases

Ming-Jie Wang, Xiao-Liang Xu, Guo-Liang Yao, Qiang Yu, Chun-Fu Zhu, Zhi-Jun Kong _, Hui Zhao, Li-Ming Tang and Xi-Hu Qin

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2016; 7:58862-58875. https://doi.org/10.18632/oncotarget.11186

Metrics: PDF 1891 views | HTML 2416 views | ?

Abstract

Ming-Jie Wang1,*, Xiao-Liang Xu2,*, Guo-Liang Yao3,*, Qiang Yu4, Chun-Fu Zhu4, Zhi-Jun Kong4, Hui Zhao5, Li-Ming Tang4 and Xi-Hu Qin4

1 Department of Orthopedics, Affiliated Hospital of Nanjing Medical University, Changzhou Second People’s Hospital, Changzhou, China

2 Liver Surgery of Jiangsu Province People’s Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China

3 Department of Thoracic Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China

4 Department of General Surgery, Affiliated Hospital of Nanjing Medical University, Changzhou Second People’s Hospital, Changzhou, China

5 Department of General Surgery, Wuxi Third People’s Hospital, Wuxi, China

* These authors have contributed equally to this study

Correspondence to:

Zhi-Jun Kong, email:

Hui Zhao, email:

Xi-Hu Qin, email:

Keywords: inflammatory bowel disease; Crohn’s disease; ulcerative colitis; MYO9B; polymorphism; Immunology and Microbiology Section; Immune response; Immunity

Received: March 25, 2016 Accepted: July 19, 2016 Published: August 19, 2016

Abstract

Myosin IXB (MYO9B) gene polymorphisms have been extensively investigated in terms of their associations with inflammatory bowel disease (IBD), with contradictory results. The aim of this meta-analysis was to evaluate associations between MY09B gene polymorphisms and the risk of IBD, Crohn’s disease (CD) and ulcerative colitis (UC). Eligible studies from PubMed, Embase, and CNKI databases were identified. Pooled odds ratios (ORs) and 95% confidence intervals (95% CIs) were calculated. Ten studies published in eight papers reporting 8,975 cases and 9,482 controls were included in this meta-analysis. Five MY09B gene polymorphisms were evaluated: rs1545620, rs962917, rs1457092, rs2305764, and rs2305767. Our data suggested that the rs1545620 polymorphism was associated with a decreased risk of IBD. A similar result was found for rs2305767 and UC. The rs962917 single nucleotide polymorphism (SNP) increased the risk of IBD, CD and UC. Moreover, rs1457092 increased the risk of IBD and UC. Rs2305764 was also associated with an increased risk of IBD. Furthermore, stratification analyses indicated that rs1545620 decreased the risk of IBD, while rs962917 increased the risk of IBD, CD and UC in Caucasian populations. To sum up, our data indicate that these five SNPs in MY09B are significantly associated with the risk of IBD.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 11186

Publication Alerts

Research Papers: Immunology:

MYO9B gene polymorphisms are associated with the risk of inflammatory bowel diseases

Abstract